Invention Grant
- Patent Title: STAT3 inhibitor
- Patent Title (中): STAT3抑制剂
-
Application No.: US14760711Application Date: 2014-01-15
-
Publication No.: US09562002B2Publication Date: 2017-02-07
- Inventor: Jia Zhou , Haijun Chen , Qiang Shen
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2014/011674 WO 20140115
- International Announcement: WO2014/113467 WO 20140724
- Main IPC: C07C235/64
- IPC: C07C235/64 ; C07D265/30 ; C07D211/40 ; A61K45/06 ; A61K31/167 ; A61K31/222 ; A61K31/381 ; A61K31/4436 ; A61K31/4465 ; A61K31/4535 ; A61K31/4709 ; A61K31/473 ; A61K31/495 ; A61K31/496 ; A61K31/5377 ; A61K9/00 ; A61K31/166 ; A61K31/18 ; A61K31/4245 ; A61K31/47 ; A61K31/5375 ; C07C235/60 ; C07C311/08 ; C07D211/46 ; C07D215/52 ; C07D295/155 ; C07D295/24 ; C07D333/54 ; C07D333/64 ; C07D409/12 ; C07D413/04

Abstract:
Provided are STAT3 inhibitors and methods of treating inflammation or a hyperproliferative disease such as, e.g., cancer. In some aspects, compounds may be used to treat breast cancer, a head/neck cancer, a lung cancer, a prostate cancer, or pancreatic cancer.
Public/Granted literature
- US20150361031A1 STAT3 INHIBITOR Public/Granted day:2015-12-17
Information query